Hou XF, Xu LP, Song HY, Li S, Wu C, Wang JF. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA. World J Gastroenterol 2017; 23(10): 1796-1803 [PMID: 28348485 DOI: 10.3748/wjg.v23.i10.1796]
Please LOGIN to submit a new comment.